- Centre de Référence
Hypertension pulmonaire
- CHU LILLE
- INSTITUT CŒUR POUMON
Filière Respifil
Les Missions du centre
- Assurer une expertise diagnostique
- Favoriser les actions de prise en charge et proposer un parcours de soins adapté pour les patients et leurs familles
La liste des pathologies concernées par le centre
- Hypertensions artérielles pulmonaires
- Hypertensions pulmonaires rares
- Hypertension thrombo-embolique chronique
- Hypertension artérielle pulmonaire idiopathique
- Hypertension artérielle pulmonaire héritable
- Hypertension artérielle pulmonaire induite par les médicaments et les toxiques
- Hypertension artérielle pulmonaire associée aux infections par le VIH
- Hypertension artérielle pulmonaire associée aux cardiopathies congénitales
- Hypertension pulmonaire associée à l’hypertension portale
- Hypertension pulmonaire associée aux connectivites
- Hypertension pulmonaire associée aux anémies hémolytiques
- Hypertension pulmonaire induite ou associée aux maladies respiratoires et/ou hypoxémies
- Hypertension pulmonaire d’origine multifactorielle non élucidée
Consultations
- Prise de rendez-vous : 03.20.44.50.38
- Lieu : consultation cardiologie, Institut Cœur Poumon, Boulevard du Professeur jules Leclercq, 59000 Lille
Service de Consultation cardiologique du CHU de Lille (chu-lille.fr)
- Pr Nicolas LAMBLIN cardiologue, médecin référent du centre
- Dr Pascal DE GROOTE, cardiologue
Vous pouvez retrouver tous les PNDS de la filière RespiFIL
| Publications | Rang auteurs |
| Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension | 1 |
| Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients. | DA |
| Right heart catheterization in advanced systolic heart failure. What are the most useful haemodynamic parameters for risk stratification? | 1 |
| Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry. | 1 |
| Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension. | 1 |
| Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. | 1 |
| Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in France. | 1 |
| Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus-associated pulmonary arterial hypertension | 1 |
| Dual-energy CT (DECT) lung perfusion in pulmonary hypertension: concordance rate with V/Q scintigraphy in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). | DA |
| Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis. | 1 |
| Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability. | DA |
| Pulmonary hypertension in systemic sclerosis: different phenotypes. | 1 |
